Showing posts with label recalls. Show all posts
Showing posts with label recalls. Show all posts

Friday, April 11, 2008

CBER's Recalls, Withdrawals, Field Corrections & Notifications Update

Update: 1

Subject: U.S. Food & Drug Administration (FDA) CBER's Recalls, Withdrawals, Field Corrections & Notifications Update

Information about CBER's Recalls, Withdrawals, Field Corrections & Notifications for U.S. Food & Drug Administration (FDA) has recently been updated, and is now available.

Recall of Thymoglobulin [Anti-thymocyte Globulin (Rabbit)] - Genzyme Corporation - 4/9/2008


Update : 2

Subject: Cracker Barrel Issues Allergy Alert on Mislabeled Chocolate-Covered Peanuts and Almonds (April 9)

Cracker Barrel Issues Allergy Alert on Mislabeled Chocolate-Covered Peanuts and Almonds (April 9)
Thu, 10 Apr 2008 10:15:00 -0500

Cracker Barrel Old Country Store, Inc. is recalling 5-ounce bags of chocolate-covered almonds and 5-ounce bags of chocolate double-dipped peanuts because the packaging is labeled incorrectly.


Update : 3

Subject: CDER New 4/9 - 10/2008

FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

CDERnew Logo

April 10, 2008

April 9, 2008


Update : 4

Subject: FDA MedWatch- CellCept (mycophenolate mofetil) and Myfortic (mycophenolate acid)-Possible Development Of Progressive Multifocal Leukoencephalopathy

MedWatch logo MedWatch - The FDA Safety Information and Adverse Event Reporting Program

FDA informed healthcare professionals that the Agency is investigating a potential association between the use of CellCept and Myfortic, medicines used to prevent organ rejection, and the development of progressive multifocal leukoencephalopathy (PML), a life-threatening disease. PML is a rare disorder that affects the central nervous system usually occurring in patients with immune systems suppressed by disease or medicines. FDA is reviewing data submitted by Roche, including postmarketing reports it has received of PML in patients who took CellCept or Myfortic, and the proposed revisions to the CellCept prescribing information. FDA has asked Novartis, the maker of Myfortic, for data on PML cases and to revise the Myfortic prescribing information to include the same information about PML included in the CellCept prescribing information. FDA anticipates it may take about 2 months to complete its review of the postmarketing reports and the proposed revisions to the prescribing information. As soon as the review is completed, FDA will communicate the conclusions and recommendations to the public.

Until further information is available, patients and healthcare professionals should be aware of the possibility of PML, such as localized neurologic signs and symptoms in the setting of a suppressed immune system, including during therapy with CellCept and Myfortic.

Read the complete 2008 MedWatch Safety Summary, including a link to the FDA Communication About an Ongoing Safety Review regarding this issue and prior MedWatch alerts regarding these products at:

http://www.fda.gov/medwatch/safety/2008/safety08.htm#mycophenolate


Update : 5
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Thu, 10 Apr 2008 14:59:02 -0500 (CDT)
Subject: FDA MedWatch - Total Body Formula, Total Body Mega Formula found to contain hazardous levels of selenium

MedWatch logo MedWatch - The FDA Safety Information and Adverse Event Reporting Program

[UPDATE] The FDA notified healthcare professionals and patients that it has found hazardous levels of selenium in samples of certain flavors of the dietary supplement products "Total Body Formula" and "Total Body Mega Formula." Analyses of samples by FDA have found most of the samples contain extremely high levels of selenium -- up to 200 times the amount of selenium indicated on the labels of the products. The FDA has received 43 reports of persons from nine states who experienced serious adverse reactions using these products. The adverse reactions generally occurred after five to 10 days of daily ingestion of the product, and included significant hair loss, muscle cramps, diarrhea, joint pain, deformed fingernails, and fatigue. Consumers should stop taking the products and consult their healthcare professional if they experience any adverse events associated with the use of the products.

Read the complete MedWatch 2008 safety summary, including a link to the FDA News Release, at:
http://www.fda.gov/medwatch/safety/2008/safety08.htm#TotalBody


This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

Thursday, March 20, 2008

U.S. Food & Drug Administration (FDA) Daily Digest Bulletin

Update: 1


Subject: CDRH New Update

Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website

FDA Home Page | CDRH Home Page | Search | A-Z Index U.S. Food and Drug AdministrationCenter for Devices and Radiological Health Questions?
horizonal rule
CDRHNEW Logo Date: March 19, 2008

The following new items were added to the CDRH web pages on March 18, 2008. Previous CDRH New Items can be found on the CDRHNew Page.

* FDA Public Health Notification: Updated Data on Mortality Associated with the Medtronic AneuRx® Stent Graft System Text
* Medical Devices Dispute Resolution Panel Advisory Meeting, April 19, 2007 - Minutes Text

---


Update : 2

Subject: Enforcement Report for March 19, 2008

Enforcement Report for March 19, 2008
Wed, 19 Mar 2008 07:17:00 -0500

Weekly report by the Food and Drug Administration, Department of Health and Human Services. It contains information on actions taken in connection with agency Regulatory activities.


Update : 3

Subject: FDA Warning Letters Update

You are subscribed to FDA Warning Letters for U.S. Food & Drug Administration (FDA). This information has recently been updated, and is now available.


Update : 4

Subject: Mortality Data Associated with the AneuRx® Stent Graft System - Medical Device Safety Update

Healthcare providers should be aware of a new public health notification that re-emphasizes the need for continued surveillance of patients treated with endovascular grafts and to provide updated information on the mortality risks associated with the use of the Medtronic AneuRx® Stent Graft System.


Update : 5

Subject: FDA Data Standards Update - Additional Section Headings' LOINC Codes & Names

Greetings,

The FDA Data Standards Council's website was updated Wednesday, March 19, 2008, to include eight new LOINC codes and names for section headings.

51941-3 - PACKAGE LABEL.BACK PANEL

51947-0 - PACKAGE LABEL.BOTTOM PANEL

51948-8 - PACKAGE LABEL.FLAP PANEL

51945-4 - PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

51944-7 - PACKAGE LABEL.SIDE PANEL

51943-9 - PACKAGE LABEL.SIDE PANEL.LEFT

51942-1 - PACKAGE LABEL.SIDE PANEL.RIGHT
51946-2 - PACKAGE LABEL.TOP PANEL

Here is the hyperlink to the web page with the new LOINC codes and names: http://www.fda.gov/oc/datacouncil/loinc.html

Lonnie Smith

Project Manager

Food and Drug Administration


Update : 6

Subject: Food For Life Baking Co., Inc. Recalls Spelt Bread (March 18)

Food For Life Baking Co., Inc. Recalls Spelt Bread (March 18)
Wed, 19 Mar 2008 10:18:00 -0500

Food For Life Baking Company of Corona, California is voluntarily recalling 2,241 cases of Spelt Bread (UPC# 07347200168) because they contain spelt grain which is known to be a hybrid of wheat. People who have allergies to wheat or those with Celiac Disease may run the risk of a serious or life threatening allergic reaction if they consume spelt products.


Update : 7

Subject: Williams Foods, Inc. Issues Allergy Alert on Undeclared Milk in Bass Pro Shops Uncle Buck's Light 'N Krispy Fish Batter Mixes (March 18)

Williams Foods, Inc. Issues Allergy Alert on Undeclared Milk in Bass Pro Shops Uncle Buck's Light 'N Krispy Fish Batter Mixes (March 18)
Wed, 19 Mar 2008 13:12:00 -0500

The product is sold in Bass Pro Shops Uncle Buck's labeled 22 ounce canisters and 8 ounce flexible pouches. This recall applies to the following lot numbers: 31207A11, 35107A11, 06308A11 (22 ounce canisters) and 3530716 (8 ounce pouches). Only the "Light 'n Krispy" version of the Bass Pro Shop's Uncle Buck's Fish Batter Mixes are affected by this recall.


Update : 8

Subject: FDA Approves New Medical Adhesive to Treat Burn Patients

FDA Approves New Medical Adhesive to Treat Burn Patients
Wed, 19 Mar 2008 16:01:00 -0500

The U.S. Food and Drug Administration today approved a new medical adhesive (a fibrin sealant) called Artiss for use in attaching skin grafts onto burn patients.



This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420